https://chinahealthreport.com/article/912824312-2025 China Health Report en PressRelease 2026-05-14T17:35:15+00:00 香港年輕生物醫學科學家鄺緯陽博士榮獲2025 福布斯中國生命科學領域殊榮 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24857048-2025-1600x1066.jpeg https://chinahealthreport.com/article/912788363-vaccine-adjuvant-market-set-to-boom-rapidly-witnessing-strong-growth-through-2033-csl-limited-seppic China Health Report en PressRelease 2026-05-14T13:08:41+00:00 Vaccine Adjuvant Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | CSL Limited, Seppic https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856817-vaccine-adjuvant-market-size-1536x1024.png https://chinahealthreport.com/article/912786516-clinical-nutrition-market-set-to-boom-rapidly-witnessing-strong-growth-through-2033-abbott-baxter-lonza China Health Report en PressRelease 2026-05-14T13:08:40+00:00 Clinical Nutrition Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | Abbott, Baxter, Lonza https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856801-clinical-nutrition-market-size-1402x1122.jpeg https://chinahealthreport.com/article/912787132-drug-discovery-market-expected-to-witness-rapid-expansion-through-2033-pfizer-inc-glaxosmithkline-llc China Health Report en PressRelease 2026-05-14T13:05:46+00:00 Drug Discovery Market Expected to Witness Rapid Expansion Through 2033 | Pfizer Inc., GlaxoSmithKline LLC https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24856804-drug-discovery-market-size-1536x1024.png https://chinahealthreport.com/article/912780374-kfsh-highlights-the-need-to-scale-ai-beyond-pilot-programs-at-trilateral-commission China Health Report en PressRelease 2026-05-14T11:58:40+00:00 KFSH Highlights the Need to Scale AI Beyond Pilot Programs at Trilateral Commission https://chinahealthreport.com/article/912345457-merit-announces-strategic-collaboration-with-mti-to-provide-spirometry-endpoints China Health Report en PressRelease 2026-05-13T18:30:00+00:00 MERIT Announces Strategic Collaboration with MTI to Provide Spirometry Endpoints https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/11363273-merit-stacked-logo-1059x639.png https://chinahealthreport.com/article/911092388-roboct-welcomes-peer-reviewed-study-on-exoskeleton-gait-rehabilitation-after-stroke China Health Report en PressRelease 2026-05-13T16:28:54+00:00 RoboCT Welcomes Peer-Reviewed Study on Exoskeleton Gait Rehabilitation After Stroke https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851090-fig-1-diagram-paper-2082x1314.png https://chinahealthreport.com/article/912546993-magventure-launches-magventure-go-portable-tms-system-to-enhance-clinical-flexibility China Health Report en PressRelease 2026-05-13T16:07:30+00:00 MagVenture Launches MagVenture Go™ Portable TMS System to Enhance Clinical Flexibility https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855625-eddie-with-mv-go-956x1280.png https://chinahealthreport.com/article/912711965-fangzhou-and-tenry-pharmaceutical-forge-strategic-partnership-to-advance-ai-powered-chronic-disease-care China Health Report en PressRelease 2026-05-14T03:21:29+00:00 Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care https://ml.globenewswire.com/media/e3ea81dc-4701-40e3-a0cd-505d016f2c8e/medium/fangzhou-and-tenry-pharmaceutical-forge-strategic-partnershi.jpg https://chinahealthreport.com/article/912533537-75-years-of-care-leading-chinese-women-s-hospital-innovating-for-women-children-worldwide China Health Report en PressRelease 2026-05-13T13:33:23+00:00 75 Years of Care: Leading Chinese Women's Hospital Innovating for Women, Children Worldwide https://ml.globenewswire.com/media/ZDFhZDU5NDYtZTA0Mi00YzJhLTkxYmUtMjFhMTJjZjhiODVjLTUwMDE2MjQ4Ni0yMDI2LTA1LTEzLWVu/tiny/Women-s-Hospital-School-of-Med.png https://chinahealthreport.com/article/912509802-innocare-announce-first-subject-dosed-in-phase-1-clinical-trial-of-icp-054-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor China Health Report en PressRelease 2026-05-13T11:43:28+00:00 InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://chinahealthreport.com/article/912446099-fangzhou-showcases-ai-h2h-chronic-disease-service-innovations-at-the-national-intelligent-medicine-conference China Health Report en PressRelease 2026-05-13T06:03:39+00:00 Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference https://ml.globenewswire.com/media/294c081f-a526-49c8-925a-1e407972f343/small/logo-compressed-png.png